Carestream’s Vue Motion Cleared for Mobile Reading

Article

Carestream Health received FDA clearance for use of its Vue Motion image view for clinical X-ray reading on mobile devices.

The approval covers reading - not just viewing - on iPhone 4s, iPad 2, Galaxy Note and Galaxy S III mobile devices, the company announced.

“Diagnostic review of X-ray images with mobile devices can expedite patient treatment decisions and enable better collaboration, which can ultimately help enhance patient care,” Neville Skudowitz, Carestream’s global product director for healthcare information solutions, said in a statement.

Carestream recommends that during diagnostic image review, radiology professions frequently and concurrently use Vue Motion viewing tools, such as zoom, pan, and window level adjustments. This will help maximize image contrast and detail sharpness of each image displayed using Vue Motion on portable and mobile devices, according to the company.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.